Ignite Creation Date:
2024-05-05 @ 11:29 AM
Last Modification Date:
2024-10-26 @ 9:08 AM
Study NCT ID:
NCT00050011
Status:
COMPLETED
Last Update Posted:
2014-03-21
First Post:
2002-11-18
Brief Title:
Zoledronic Acid - Letrozole Adjuvant Synergy Trial ZFAST - Cancer Treatment Related Bone Loss in Postmenopausal Women With Estrogen Receptor Positive andor Progesterone Receptor Positive Breast Cancer Receiving Adjuvant Hormonal Therapy
Sponsor:
Novartis Pharmaceuticals
Organization:
Novartis
Organization Data
Organization:
Novartis
Class:
INDUSTRY
Study ID:
CZOL446EUS32
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Novartis Pharmaceuticals
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None